Barrish A - Search Results

1

Disposition of a novel and potent alpha(v)beta3 antagonist in animals, and extrapolation to man.

Prueksaritanont T, Fernandez-Metzler C, Meng Y, Barrish A, Halczenko W, Rodan SB, Hutchinson JH, Duggan ME, Lin JH. Prueksaritanont T, et al. Among authors: barrish a. Xenobiotica. 2004 Jan;34(1):103-15. doi: 10.1080/713767592. Xenobiotica. 2004. PMID: 14742139

2

Non-peptide alpha(v)beta(3) antagonists. Part 5: identification of potent RGD mimetics incorporating 2-aryl beta-amino acids as aspartic acid replacements.

Brashear KM, Hunt CA, Kucer BT, Duggan ME, Hartman GD, Rodan GA, Rodan SB, Leu CT, Prueksaritanont T, Fernandez-Metzler C, Barrish A, Homnick CF, Hutchinson JH, Coleman PJ. Brashear KM, et al. Among authors: barrish a. Bioorg Med Chem Lett. 2002 Dec 2;12(23):3483-6. doi: 10.1016/s0960-894x(02)00743-6. Bioorg Med Chem Lett. 2002. PMID: 12419389

3

Renal elimination of a novel and potent alphavbeta3 integrin antagonist in animals.

Prueksaritanont T, Hochman JH, Meng Y, Pudvah NT, Barrish A, Ma B, Yamazaki M, Fernandez-Metzler C, Lin JH. Prueksaritanont T, et al. Among authors: barrish a. Xenobiotica. 2004 Nov-Dec;34(11-12):1059-74. doi: 10.1080/00498250400015277. Xenobiotica. 2004. PMID: 15801548

4

Nonlinear dorzolamide pharmacokinetics in rats: concentration-dependent erythrocyte distribution and drug-metabolite displacement interaction.

Wong BK, Bruhin PJ, Barrish A, Lin JH. Wong BK, et al. Among authors: barrish a. Drug Metab Dispos. 1996 Jun;24(6):659-63. Drug Metab Dispos. 1996. PMID: 8781782

5

Determination of MK-852, a new fibrinogen receptor antagonist, in plasma and urine by radioimmunoassay.

Yuan AS, Hand EL, Hichens M, Olah TV, Barrish A, Fernandez-Metzler C, Gilbert JD. Yuan AS, et al. Among authors: barrish a. J Pharm Biomed Anal. 1993 Jun;11(6):427-34. doi: 10.1016/0731-7085(93)80153-r. J Pharm Biomed Anal. 1993. PMID: 8399513

6

The development and cross-validation of methods based on radioimmunoassay and LC/MS-MS for the quantification of the class III antiarrhythmic agent, MK-0499, in human plasma and urine.

Gilbert JD, Greber TF, Ellis JD, Barrish A, Olah TV, Fernández-Metzler C, Yuan AS, Burke CJ. Gilbert JD, et al. Among authors: barrish a. J Pharm Biomed Anal. 1995 Jul;13(8):937-50. doi: 10.1016/0731-7085(95)01540-2. J Pharm Biomed Anal. 1995. PMID: 8580153

7

In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.

Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C. Barrow JC, et al. Among authors: barrish a. J Med Chem. 2000 Jul 13;43(14):2703-18. doi: 10.1021/jm990612y. J Med Chem. 2000. PMID: 10893308

8

The use of stable isotope labeling and liquid chromatography/tandem mass spectrometry techniques to study the pharmacokinetics and bioavailability of the antimigraine drug, MK-0462 (rizatriptan) in dogs.

Barrish A, Olah TV, Gatto GJ, Michel KB, Dobrinska MR, Gilbert JD. Barrish A, et al. Rapid Commun Mass Spectrom. 1996;10(9):1033-7. doi: 10.1002/(SICI)1097-0231(19960715)10:9<1033::AID-RCM616>3.0.CO;2-4. Rapid Commun Mass Spectrom. 1996. PMID: 8755236

9

Determination of L-654,066, a new 5 alpha-reductase inhibitor in plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry.

Gilbert JD, Olah TV, Barrish A, Greber TF. Gilbert JD, et al. Among authors: barrish a. Biol Mass Spectrom. 1992 Jul;21(7):341-6. doi: 10.1002/bms.1200210704. Biol Mass Spectrom. 1992. PMID: 1420375

10

Plasma timolol concentrations of timolol maleate: timolol gel-forming solution (TIMOPTIC-XE) once daily versus timolol maleate ophthalmic solution twice daily.

Shedden AH, Laurence J, Barrish A, Olah TV. Shedden AH, et al. Among authors: barrish a. Doc Ophthalmol. 2001 Jul;103(1):73-9. doi: 10.1023/a:1017962731813. Doc Ophthalmol. 2001. PMID: 11678162 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page